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1. Introduction 
The lipase released from the liver after intravenous 
injection of heparin (liver lipase, EC 3 .l .1.3) has a 
broad substrate specificity [l-3]. Hydrolysis of ester 
bonds in triacylglycerol, diacylglycerols, 1 or 2 mono- 
acylglycerols, pahnitoyl-coenzyme A and phosphatid- 
ylcholine (the 1 acyl ester bond) has been demon- 
strated, using artificial lipid emulsions. Although a 
role in serum lipoprotein metabolism has generally 
been considered, the physiological function of this 
enzyme has not been well established. Evidence has 
been presented, based on in vivo inhibition of liver 
lipase by intravenous injection of a specific antiserum 
in rats, that liver lipase is involved in HDL and pos- 
sibly LDL-phospholipid catabolism [4-61. Based on 
these experiments a role of liver lipase in the conver- 
sion of HDL-2 into HDL3 was proposed. This hypoth- 
esis was developed further by in vitro incubations of 
liver lipase with rat HDL-2 [7] and by in vivo turnover 
studies of HDLphospholipids and cholesterol esters 
[8]. Here, the hypothesis was further investigated. As 
HDL2 and HDL3 are poorly defmed in rat, we turned 
to human serum and measured the phospholipase A 
activity of purified human heparin-releasable liver 
lipase with isolated HDL-2 and HDL-3. It was found 
that the rate of phosphatidylcholine hydrolysis with 
HDL2 as substrate exceeds the rate with HDL3 by a 
factor of -10. These data provide further evidence for 
a role of liver lipase in the degradation of HDL-2. 
Abbreviations: HDL, high density lipoprotein; LDL, low den- 
sity lipoprotein; PLEP, phospholipid exchange protein; 
VLDL, very low density lipoprotein 
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2. Materials and methods 
2 .l . The purification of human liver lipase 
Post-heparin blood was obtained from fasted volun- 
teers, 6 min after the intravenous injection of heparin 
(50 U/kg body wt) and plasma was obtained by low 
speed centrifugation. Liver lipase was purified from the 
plasma by affinity chromatography on Sepharose4B 
containing covalently bound heparin [9]. The enzyme 
was eluted with a linear NaCl gradient (0.2-2 M) in 
5 mM sodium barbital (pH 7.4) containing 20% (v/v) 
glycerol. Liver lipase (eluted at -0.8 M NaCl) was 
completely separated from lipoprotein lipase (eluted 
at -1.3 M NaCl) and its specific activity increased 
-250-fold. An additional 5-fold purification was 
accomplished on a second heparin-Sepharose column 
operated exactly as in [lo]. Top fractions, eluted at 
-0.8 M NaCl concentration, hydrolyzed a triolein 
substrate with spec. act. 4.3 pm01 fatty acid 
released . min-’ . mg protein-‘, using the assay condi- 
tions in [3], including 1 M NaCl (table 1). The enzyme 
was stored at -20°C in 0.8 M NaCl, 5 mM sodium 
barbital buffer (pH 7.4), 0.2% bovine serum albumin 
and 20% (v/v) glycerol. Before use the enzyme was 
concentrated and dialyzed against 0.9% NaCl, 5 mM 
sodium barbital buffer (pH 7.4) using a hollow fiber. 
2.2. Preparation of human lipoproteins labeled in vitro 
in their phosphatidylcholine moiety 
Fresh human sera of fasted, healthy, female donors 
were labeled in their phosphatidylcholine moiety by 
exchange with phosphatidyl [methyZ-3H] choline pres- 
ent in purified rat liver microsomes, using the phos- 
phatidylcholine exchange protein from bovine liver 
(PC-PLEP), essentially as has been described [ 111. 
Phosphatidyl[3H]choline labeled rat liver microsomes 
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Table 1 
The purification of human liver lipase 
Fraction Vol. 
(ml) 
Protein 
(mg) 
Lipase 
activity (U) 
Spec. act. Recovery 
(U/mg protein) (%) 
Postheparin plasma 90 5400 18 0.0033 100 
Peak activity 1st 
heparin-Sepharose column 83 6.6 5.58 0.84 31 
Peak activity 2nd 
heparin-Sepharose column 27 0.39 1.7 4.3 9.4 
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were prepared by incubation of microsomes with 
[methyZ-3H]choline  the presence of 0.16 mM CaCl, 
[ 121. Microsomes (2.2 ~01 phospholipid containing 
8.8 X lo6 dpm), human serum (6 ml containing 
-20 pmol lipoprotein phospholipid) and pure 
PCPLEP [ 131 (0.045 mg; a generous gift from 
Dr K. W. A. Wirtz) were mixed and incubated for 1 h 
at 37°C. Next the microsomes were spun down (1 h 
at 47 000 rev./min in a Beckman 50 rotor at 4’C). 
About 90% of the radioactivity was associated with 
serum lipoproteins, mainly e95%) with phosphatidyl- 
choline. Net transfer of phospholipid id not occur 
during our labeling procedure as the phospholipid 
phosphorus concentrations in serum and microsomes 
were not affected by the incubation. 
2.3. Isolation of HDL-2 and HDL-3 
HDL2 and HDL3 were isolated from prelabeled 
sera by density gradient ultracentrifugation, essentially 
as in [ 141. Serum lipoprotein separation was accom- 
plished by centrifugation for 45 h at 40 000 rev./min 
at 15°C in the Beckman SW 40 rotor. After centrif- 
ugation two HDL bands were clearly visible in the 
lower part of the tube and were harvested by tube 
slicing at predetermined positions. The density profile 
after centrifugation was determined in control gra- 
dients using a precision density meter (Anton Paar, 
Graz, model DMA 40) and used to determine the 
cut-off densities of the HDL2 and HDL3 fractions 
(HDL2, 1.07 < d < 1 .l 1 g/ml; and HDL3, 
1 .11 < d < 1 .I75 g/ml). Lipoprotein fractions were 
dialyzed against 0.9% NaCl, 1 mM EDTA, 10 mM 
Tris-HCI (pH 7.4), 0.1% NaN3 and stored at 4°C 
under nitrogen. 
2.4. Incubation of HDL fractions with purified liver 
lipase 
HDL (0.25 mM phospholipid) was incubated with 
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or without liver lipase (-10 mU if measured with tri- 
olein as substrate) in a medium containing 150 mM 
NaCl, 40 mM Tris-HCl (pH 7.4) 0.5 mM CaCl, and 
1% defatted bovine serum albumin for 30 or 60 min 
in a final volume of 0.1 ml at 37°C. The incubation 
was terminated by a chloroform-methanol extraction 
as in [ 151. The radioactivity in the chloroform phase 
associated with lysophosphatidylcholine was deter- 
mined after the separation of phospholipids by thin 
layer chromatography onSilica gel using chloroform- 
methanol-acetic acid-water (100:50:18:8, by vol.). 
2.5. Other methods 
Triacylglycerol lipase activity of liver lipase was 
determined with a triolein emulsion stabilized by gum 
acacia s in [3], except hat 1 M NaCl was used. The 
enzyme activity is expressed in /.unol fatty acid 
released/mm incubation at 30°C. 
Phospholipid phosphorus, protein, cholesterol and 
cholesterol esters were determined as in [7]. 
3. Results and discussion 
Human HDL fractions were labeled in vitro in their 
phosphatidylcholine moiety using a specific exchange 
protein isolated from bovine liver which facilitates 
exchange of phosphatidylcholine b tween membranes 
and lipoproteins [111. The chemical composition of 
phosphatidyl[ 3H] choline-labeled HDL2 and HDL3 
is shown in table 2. HDL-2 is enriched in all lipid 
components and poor in protein in comparison with 
HDL3, as has been shown before for HDL2 and 
HDL3 separated by zonal ultracentrifugation [ 16,171. 
The concentration of HDL2 is -l/2 that of HDL3 
in the sera of our (female) blood donors see legend 
table 2; a slightly lower ratio was described in [ 161 in 
a normal female population. 
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Table 2 
Chemical composition (weight % + SD, n = 4) of human HDL-2 and HDL3 
labeled in the phosphatidylcholine moiety 
Chemical composition 
Protein Phospholipid Free 
cholesterol 
Cholesterol 
ester 
HDL-2 38.4 ?: 2.89 34.3 f 2.24 4.9 + 0.90 22.3 f 4.10 
HDL3 52.8 f 1.07 26.6 2 259 2.5 + 0.12 18.1 +2.86 
For details see section 2. The specific radioactivity of phosphatidylcholine in 
HDL-2 and HDL3 was 397 + 32 and 441 i: 46 dpm/nmol phospholipid phospho- 
IUS, respectively. The serum concentrations of HDL-2 and HDL3, calculated from 
the chemical composition, were 1.15 f 0.34 and 2.17 f 0.26 mg/ml serum,respec- 
tively. Molecular masses of phospholipid and cholesterol esters in HDL were 
assumed to be 775 and 644,respectively, HDL triglycerides were not measured 
Isolated HDL-2 and HDL3 fractions were incu- 
bated with liver lipase and the generation of radio- 
labeled lysophosphatidylcholine was determined by 
thin-layer chromatography. The results are shown in 
table 3. The rate of HDL-2 phosphatidylcholine 
hydrolysis exceeded that of HDL3 by a factor of 5 or 
more in all individual experiments. Under the condi- 
tions, shown in table 3, a linear elationship between 
incubation time and lysophosphatidylchohne forma- 
tion was found (not shown). To determine the kinetic 
parameters for HDL2 phosphatidylcholine hydrolysis 
by human liver lipase, a substrate saturation study 
was undertaken. The results are shown in fig.1. The 
app. Km for HDL2 phosphatidylcholine hydrolysis 
(0.1 mM) is lower than the serum concentration 
(0.1-0.40mM HDL2 phospholipid phosphorus). Our 
Table 3 
Hydrolysis of phosphatidyl[ ‘HIcholine on isolated HDL-2 
and HDL3 by human liver lipase 
Lysophosphatidylcholine formed (nmol/h) 
mean+-SD(n=4) 
HDL-2 1.90 f 0.14 
HDL-3 0.16 + 0.19 
HDL-2 or HDL3 were incubated with or without humanliver 
lipase (8-16.6 mU as measured with a triolein substrate on 
the day of the experiment) and the liver lipasedependent 
lysophosphatidylcholine formation was determined as in sec- 
tion 2. For comparison the data are normalized as if 16.6 mU 
liver lipase (with triolein as substrate) had been added in all 
experiments. HDL phospholipid phosphorus was 0.25 mM; 
incubation was for 60 mm 
assay system did not allow an accurate measurement 
of the Km for HDL3. 
Human HDL2 and HDL-3 are interrelated. A
HDL2 like particle can be formed from HDL3 in vitro 
during VLDL catabolism by lipoprotein lipase [ 181 
and an increased lipolysis in man in vivo has also been 
connected with an increased HDL2 concentration 
[ 191. HDL-2 particles are larger and contain 2-3-times 
more phospholipid, cholesterol and cholesterol ester 
than HDL3 particles [20]. The conversion of HDL3 
into HDL2 could be the result of uptake of surface 
lipids and apolipoproteins (C and A-l) from VLDL 
and chylomicrons during lipolysis, followed by cho- 
Fig.1. Substrate saturation of HDL-2 phosphatidyl[ )H]cho- 
line hydrolysis by human liver lipase. Insert: Lineweaver-Burk 
plot (l/V vs l/S, of the data. The Km calculated from the 
data was 0.1 mM HDL-2 phospholipid phosphorus; incuba- 
tion time 60 min. 
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lesterolesterification bylecithin:cholesterol acyltrans- 
ferase. A scheme has been proposed for the reverse 
process, e.g., the conversion of HDL2 into HDL3 
[5-81. In that scheme liver lipase hydrolyzes HDL2 
phosphatidylcholine. Asthe surface of HDL2 shrinks 
by such process, its cholesterol and cholesterol esters 
may be transferred, possibly to organs equipped with 
a liver lipase (in addition to the liver also present in
the adrenals and ovaries [2 1,221) or to other plasma 
lipoproteins. These data support hat hypothesis, as 
HDL2 phosphatidylcholine is a superior substrate for 
liver lipase compared to HDL3. The origin of this 
preference isnot yet understood. It may be connected 
with differences in the composition of the apolipo- 
protein moiety of HDL2 (a higher content of apo C 
peptides and apo E, a higher apo A-I/ape A-II ratio) 
relative to HDL3. However in preliminary studies we 
were unable to demonstrate effects of addition of 
apo E and apo C-I to the incubation medium on 
HDL3 phosphatidylcholine hydrolysis. Alternatively 
the physical state of HDL (i.e., radius of curvature or 
surface pressure) could determine the rate of phospho- 
lipid hydrolysis but obviously more experiments are 
needed to clarify this point. 
HDL2 may be a subfraction of HDL which links 
several pathways of lipoprotein metabolism. However, 
HDL-3 is often taken to be representative for total 
plasma HDL. The big difference in properties between 
the HDL subfractions, as described here, stresses the 
importance of the use of HDL-2 in addition to HDL3 
in metabolic and cell interaction studies. 
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